PARIS: A study of nearly 100,000 coronavirus patients has shown no benefit in treating them with anti-viral drugs hydroxychloroquine and chloroquine and even increased the likelihood of them dying in hospital.

Hydroxychloroquine is normally used to treat arthritis but pronouncement from public figures including US President Donald Trump — who announced this week he is taking the drug — has prompted governments to bulk buy the medicine.

Chloroquine is an anti-malarial. Both drugs can produce potentially serious side effects, particularly heart arrhythmia. And neither drug benefitted patients hospitalised with Covid-19, according to a study published on Friday in The Lancet.

Looking at the records of 96,000 patients across hundreds of hospitals, they found that administering the drugs actually increased the risk of dying.

They compared outcomes from four groups: those treated with hydroxychloroquine alone, with chloroquine alone, and then two groups given the respective drugs in combination with antibiotics. There was also a control group of patients not given these treatments.

Report on the study involving 100,000 coronavirus patients has been published in Lancet

At the end of the study period around nine per cent of those in the control group had died. Of those treated with hydroxychloroquine or chloroquine alone, 18 per cent and 16.4 per cent respectively had died.

And those given each drug in combination with antibiotics were even more likely to die: 22.8 per cent with chloroquine and 23.8 per cent with hydroxychloroquine.

The authors estimated that the drugs put patients at up to 45 per cent higher risk of dying from Covid-19 compared with underlying health issues.

“Treatment with chloroquine or hydroxychloroquine does not benefit patients with Covid-19,” said Mandeep Mehra, lead author of the study and executive director of the Brigham and Women’s Hospital Centre for Advanced Heart Disease in Boston.

“Instead, our findings suggest it may be associated with an increased risk of serious heart problems and increased risk of death.”

Despite Trump’s enthusiasm for using hydroxychloroquine for Covid-19 treatment, his own government’s Food and Drug Administration warns against it.

Brazil’s health minister on Wednesday recommended using chloroquine and hydroxychloroquine to treat even mild Covid-19 cases.

Britain has ordered $42 million worth of hydroxychloroquine, despite numerous studies showing it is ineffective in treating Covid-19 and may even be more dangerous than doing nothing.

“Several countries have advocated use of chloroquine and hydroxychloroquine, either alone or in combination, as potential treatments for Covid-19,” said Frank Ruschitzka, director of the Heart Centre at University Hospital Zurich and co-author of the study.

“We now know from our study that the chance that these medications improve outcomes in Covid-19 is quite low.” Stephen Griffin, associate professor at the University of Leeds’ School of Medicine said the Lancet research was “potentially a landmark study for Covid-19 therapy”.

“The indications are that these drugs certainly ought not to be used outside of a trial setting where patients can be monitored for complications,” said Griffin, who was not involved in the study.

“It is clear that high-profile endorsements for taking these drugs without clinical oversight is both misguided and irresponsible.”

Published in Dawn, May 23rd, 2020

Opinion

New engagement
Updated 19 Apr 2021

New engagement

Better Pak-India ties mean a better regional outcome.
Inequality and ideology
19 Apr 2021

Inequality and ideology

Hunger and want, and the constant reminder of inequality,may condition religious mobilisation, but they are not solely sufficient.
Ties of sentiment
19 Apr 2021

Ties of sentiment

Pakistan-UK relations have been remarkably stable and increasingly energised by the Pakistani diaspora.

Editorial

19 Apr 2021

Vaccine shortfall

THE hope that the slew of Covid-19 vaccinations approved for use since the end of last year would vanquish the ...
Another package
Updated 19 Apr 2021

Another package

Sindh has not seen much development worth the name during the PPP’s more than decade-long rule in the province.
19 Apr 2021

Cricket triumph

TEAM Pakistan have a number of reasons to rejoice after their 3-1 T20 series win over hosts South Africa on Friday....
18 Apr 2021

More cabinet changes

PRIME MINISTER Imran Khan has reshuffled his cabinet yet again in what is obviously another attempt to shore up his...
Blocking social media
Updated 18 Apr 2021

Blocking social media

FOR four hours this week, all social media platforms in the country were shut down, a measure the government said ...
18 Apr 2021

Peasant rights in Sindh

IN a seminar held in Nawabshah recently, the Sindh Human Rights Commission and Hari Welfare Association reiterated a...